IQV

IQVIA Holdings Inc.

Price

$264.03

return (12m)

40.68%

p/e

32.34

p/bv

7.08

DIVIDEND YIELD

0.00%

IQV price

IQVIA Holdings

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment IQV

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

9.19%

3 months

41.76%

1 year

40.68%

2 years

8.62%

5 years

0.81%

10 years

239.63%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals IQV

Valuation

P/E

32.34

Sector 0.57

Industry 6.93

P/BV

7.08

Sector 1.90

Industry 1.33

P/Revenue (PSR)

2.63

Sector 1.58

Industry 0.55

EV/EBITDA

71.17

Sector -48.61

Industry -38.44

EV/EBIT

112.89

Sector -28.36

Industry 7.97

P/EBITDA

12.64

Sector -38.03

Industry -4.41

P/EBIT

19.02

Sector -43.90

Industry -3.47

P/Total Assets

1.49

Sector 0.90

Industry 0.56

P/Net Current Assets

-2.57

Sector -23.20

Industry -12.23

P/Working Capital

-17.23

Sector -4.39

Industry -49.24

EPS

8.30

Sector -0.70

Industry -0.47

BVPS

37.93

Sector 4.03

Industry 6.07

Efficiency

Gross Margin

32.97%

Sector 49.10%

Industry 45.93%

EBITDA Margin

18.09%

Sector -313.26%

Industry -72.01%

EBIT Margin

11.40%

Sector -182.06%

Industry -10.15%

Operating Margin

12.95%

Sector -20.87%

Industry -5.34%

Net Profit Margins

8.12%

Sector -25.33%

Industry -14.94%

Asset Turnover

0.15

Sector 0.13

Industry 0.22

Profitability

ROE

21.89%

Sector -25.69%

Industry -28.63%

ROA

4.61%

Sector -25.32%

Industry -14.95%

ROIC

6.43%

Sector -589.68%

Industry -110.50%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

0.71

Sector 1.89

Industry 1.14

Net Debt / EBITDA

14.72

Sector -21.45

Industry -31.77

Net Debt / EBIT

23.34

Sector -3.01

Industry 2.06

Net Debt / Equity

1.84

Sector -0.62

Industry 0.01

Gross Debt / Equity

2.18

Sector 0.11

Industry 0.46

Equity/Assets

0.21

Sector 0.45

Industry 0.30

Liabilities/Assets

0.79

Sector 0.49

Industry 0.60

Growth

5Y Revenue CAGR

4.13%

Sector -

Industry -

5Y Earnings CAGR

7.27%

Sector -

Industry -

Fundamentals IQV

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF IQVIA Holdings ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$264.03

Fair Value

$84.16

Upside Return potential.

-68.12%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
IQV IQVIA Holdings Inc.	$264.03	40.68%	0.00%	32.34	7.08	21.89%	8.12%
TMO Thermo Fisher Scientific Inc.	$605.88	23.53%	0.29%	32.67	4.33	13.26%	15.08%
DHR Danaher Corporation	$206.40	4.68%	0.69%	36.61	2.79	7.61%	15.95%
WAT Waters Corporation	$404.59	30.78%	0.00%	244.45	2.67	1.09%	3.58%
SHC Sotera Health Company	$18.71	19.78%	0.00%	33.20	8.15	24.56%	13.44%
CGEN Compugen Ltd.	$2.61	82.17%	0.00%	8.87	2.75	31.01%	36.12%
SYNH Syneos Health Inc.	$0.00	-	0.00%	62.97	1.28	2.04%	1.31%
LLY Eli Lilly and Compay	$1,121.43	53.12%	0.56%	38.25	-	-%	33.53%
ISRG Intuitive Surgical Inc.	$365.46	-17.16%	0.00%	40.98	7.07	17.26%	28.62%
SNY Sanofi	$43.37	-3.06%	4.00%	4.14	0.76	18.43%	14.25%
NVS Novartis AG	$137.72	8.22%	1.94%	23.95	7.28	30.39%	23.28%
ABT Abbott Laboratories	$105.70	-18.22%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.65	3.78%	3.04%	22.82	2.36	10.35%	14.02%
GSK GlaxoSmithKline PLC	$48.60	25.51%	3.51%	15.52	4.38	28.24%	14.54%
BSX Boston Scientific Corp.	$45.82	-57.27%	0.00%	19.32	2.85	14.73%	17.49%
TMDX TransMedics Group Inc.	$88.23	-15.18%	0.00%	19.90	5.83	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$525.66	-18.25%	0.00%	36.90	26.08	70.67%	25.03%
RMD ResMed Inc.	$221.30	-19.11%	1.06%	21.68	5.07	23.41%	27.44%
HCA HCA Healthcare Inc.	$402.41	-3.73%	0.74%	11.38	-27.86	-244.72%	10.07%
COHR Coherent Inc.	$281.86	188.08%	0.00%	118.83	4.88	4.11%	6.85%
SYK Stryker Corp.	$280.78	-27.51%	1.15%	31.24	4.86	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

IQV Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT IQVIA Holdings

IQVIA Holdings Inc.

Average Investor10 user rating

4.0 (4 people)

United States

44 years

Founded: 1982

2013

Time since IPO - 13 years

79.000

Employees

IQVIA Holdings Inc. (United States) is listed on the NYSE and has a market capitalization of $44.60 billion, with shareholders equity totaling $6.30 billion.

The company employs approximately 79.000 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, IQVIA Holdings Inc. reported $16.98 billion in revenue, generating net income of $1.38 billion.

Key financial metrics include a P/E ratio of 32.34, a price-to-book (P/B) ratio of 7.08, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker IQV.

Market cap

$44.60 billion

Net worth

$6.30 billion

$6,301,000,000.00

Assets

$29.88 billion

$29,881,000,000.00

Total Shares Outstanding

166.10 million

166,100,000

Average Daily Trading Volume

$1.38 million

$1,377,821.40

Sector

Health

Industry

Life Science Tools and Services

IQV

revenue by Business Segment IQVIA Holdings

Revenue by Region IQVIA Holdings

IQV revenue and profits

Financial Results IQV

DRAG THE FRAME TO SEE MORE DATA

IQV cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$95.95 40,88% (12M)

P/E

-0.87

2.73%

ROE

-178.93%

P/BV

1.56

CI - Cigna

$276.24 --5,64% (12M)

P/E

10.92

2.17%

ROE

16.04%

P/BV

1.75

CNC - Centene

$65.24 126,21% (12M)

P/E

-6.55

0.00%

ROE

-22.56%

P/BV

1.48

HUM - Humana

$403.48 31,88% (12M)

P/E

37.56

0.88%

ROE

6.72%

P/BV

2.52

SNY - Sanofi

$43.37 --3,69% (12M)

P/E

4.14

4.00%

ROE

18.43%

P/BV

0.76

LLY - Eli Lilly

$1,121.43 53,12% (12M)

P/E

38.25

0.56%

ROE

P/BV

HCA - HCA Healthcare

$402.41 --3,12% (12M)

P/E

11.38

0.74%

ROE

-244.72%

P/BV

-27.86

NVS - Novartis

$137.72 9,06% (12M)

P/E

23.95

1.94%

ROE

30.39%

P/BV

7.28